Part 1: Why test?
5 May 2026
Part 1: Why test?
Part 2: How to get biopsies for testing?
Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing
First real-world study of penile cancer in Bolivia reveals high HPV-related rates and advanced disease
Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies